South Korea ensures the quality of active pharmaceutical ingredients (APIs) through stringent regulations set by the Ministry of Food and Drug Safety (MFDS). Manufacturers must comply with Good Manufacturing Practices (GMP), undergo regular inspections, and submit detailed quality control data. APIs are tested for purity, potency, and consistency before approval for drug manufacturing.
